These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8529963)

  • 1. [Prostacyclin mimetics with non-prostanoid structures].
    Kondo K; Hamanaka N
    Nihon Yakurigaku Zasshi; 1995 Sep; 106(3):181-91. PubMed ID: 8529963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
    Chow KB; Wong YH; Wise H
    Br J Pharmacol; 2001 Dec; 134(7):1375-84. PubMed ID: 11724742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.
    Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
    Br J Pharmacol; 1993 Dec; 110(4):1600-6. PubMed ID: 8306107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon.
    Rudd JA; Qian Ym; Tsui KK; Jones RL
    Br J Pharmacol; 2000 Feb; 129(4):782-90. PubMed ID: 10683203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS; Wharton KA; White BP; Lumley P
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel prostaglandin I2 mimetic ONO-1301 escapes desensitization in an antiplatelet effect due to its inhibitory action on thromboxane A2 synthesis in mice.
    Kashiwagi H; Yuhki K; Kojima F; Kumei S; Takahata O; Sakai Y; Narumiya S; Ushikubi F
    J Pharmacol Exp Ther; 2015 May; 353(2):269-78. PubMed ID: 25740898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prostacyclin agonist with thromboxane inhibitory activity for airway allergic inflammation in mice.
    Hayashi M; Koya T; Kawakami H; Sakagami T; Hasegawa T; Kagamu H; Takada T; Sakai Y; Suzuki E; Gelfand EW; Gejyo F
    Clin Exp Allergy; 2010 Feb; 40(2):317-26. PubMed ID: 20015276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZD9583, an orally effective thromboxane A2 synthase inhibitor and receptor antagonist with a sustained duration of action in rat and dog.
    Brownlie RP; Brownrigg NJ; Butcher HM; Garcia R; Jessup R; Lee VJ; Tunstall S; Wayne MG
    J Pharm Pharmacol; 1997 Feb; 49(2):187-94. PubMed ID: 9055193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical pharmacology of thromboxane synthase inhibition in man.
    FitzGerald GA; Reilly IA; Pedersen AK
    Circulation; 1985 Dec; 72(6):1194-201. PubMed ID: 3905048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ONO-AP-500-02: a non prostanoid prostaglandin I2 mimetic with inhibitory activity against thromboxane synthase.
    Kondo K; Machii K; Narita M; Kawamoto A; Yamasaki S; Hamanaka N
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():401-3. PubMed ID: 7732882
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension.
    Nakamura A; Nagaya N; Obata H; Sakai K; Sakai Y; Yoshikawa M; Hamada K; Matsumoto K; Kimura H
    Circ J; 2013; 77(8):2127-33. PubMed ID: 23676973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice.
    Murakami S; Nagaya N; Itoh T; Kataoka M; Iwase T; Horio T; Miyahara Y; Sakai Y; Kangawa K; Kimura H
    Am J Physiol Lung Cell Mol Physiol; 2006 Jan; 290(1):L59-65. PubMed ID: 16155090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New trends in thromboxane and prostacyclin modulators.
    Dogné JM; de Leval X; Delarge J; David JL; Masereel B
    Curr Med Chem; 2000 Jun; 7(6):609-28. PubMed ID: 10702629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury.
    Hirata Y; Shimabukuro M; Uematsu E; Soeki T; Yamada H; Sakai Y; Nakayama M; Matsumoto K; Igarashi T; Sata M
    Eur J Pharmacol; 2012 Jan; 674(2-3):352-8. PubMed ID: 22094066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
    Dickinson RP; Dack KN; Long CJ; Steele J
    J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA; Doran JB; Smith B; FitzGerald GA
    Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.